NM_016203.4:c.864+35_864+36insA

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP6_Very_StrongBA1

The NM_016203.4(PRKAG2):​c.864+35_864+36insA variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.746 in 1,537,102 control chromosomes in the GnomAD database, including 430,414 homozygotes. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.73 ( 40657 hom., cov: 0)
Exomes 𝑓: 0.75 ( 389757 hom. )

Consequence

PRKAG2
NM_016203.4 intron

Scores

Not classified

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: -3.41

Publications

5 publications found
Variant links:
Genes affected
PRKAG2 (HGNC:9386): (protein kinase AMP-activated non-catalytic subunit gamma 2) AMP-activated protein kinase (AMPK) is a heterotrimeric protein composed of a catalytic alpha subunit, a noncatalytic beta subunit, and a noncatalytic regulatory gamma subunit. Various forms of each of these subunits exist, encoded by different genes. AMPK is an important energy-sensing enzyme that monitors cellular energy status and functions by inactivating key enzymes involved in regulating de novo biosynthesis of fatty acid and cholesterol. This gene is a member of the AMPK gamma subunit family. Mutations in this gene have been associated with Wolff-Parkinson-White syndrome, familial hypertrophic cardiomyopathy, and glycogen storage disease of the heart. Alternate transcriptional splice variants, encoding different isoforms, have been characterized. [provided by RefSeq, Jan 2015]
PRKAG2 Gene-Disease associations (from GenCC):
  • hypertrophic cardiomyopathy
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • hypertrophic cardiomyopathy 6
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, PanelApp Australia, Labcorp Genetics (formerly Invitae)
  • PRKAG2-related cardiomyopathy
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • lethal congenital glycogen storage disease of heart
    Inheritance: AD Classification: STRONG Submitted by: PanelApp Australia, Genomics England PanelApp
  • Wolff-Parkinson-White syndrome
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

BP6
Variant 7-151595309-A-AT is Benign according to our data. Variant chr7-151595309-A-AT is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 260697.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.961 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PRKAG2NM_016203.4 linkc.864+35_864+36insA intron_variant Intron 6 of 15 ENST00000287878.9 NP_057287.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PRKAG2ENST00000287878.9 linkc.864+35_864+36insA intron_variant Intron 6 of 15 1 NM_016203.4 ENSP00000287878.3

Frequencies

GnomAD3 genomes
AF:
0.728
AC:
110640
AN:
151882
Hom.:
40603
Cov.:
0
show subpopulations
Gnomad AFR
AF:
0.668
Gnomad AMI
AF:
0.512
Gnomad AMR
AF:
0.733
Gnomad ASJ
AF:
0.733
Gnomad EAS
AF:
0.984
Gnomad SAS
AF:
0.843
Gnomad FIN
AF:
0.775
Gnomad MID
AF:
0.684
Gnomad NFE
AF:
0.731
Gnomad OTH
AF:
0.747
GnomAD2 exomes
AF:
0.764
AC:
186641
AN:
244310
AF XY:
0.768
show subpopulations
Gnomad AFR exome
AF:
0.670
Gnomad AMR exome
AF:
0.739
Gnomad ASJ exome
AF:
0.736
Gnomad EAS exome
AF:
0.983
Gnomad FIN exome
AF:
0.786
Gnomad NFE exome
AF:
0.730
Gnomad OTH exome
AF:
0.752
GnomAD4 exome
AF:
0.748
AC:
1035486
AN:
1385102
Hom.:
389757
Cov.:
23
AF XY:
0.750
AC XY:
519840
AN XY:
693320
show subpopulations
African (AFR)
AF:
0.669
AC:
21269
AN:
31790
American (AMR)
AF:
0.739
AC:
32733
AN:
44316
Ashkenazi Jewish (ASJ)
AF:
0.740
AC:
18968
AN:
25618
East Asian (EAS)
AF:
0.986
AC:
38733
AN:
39294
South Asian (SAS)
AF:
0.830
AC:
70006
AN:
84350
European-Finnish (FIN)
AF:
0.783
AC:
40184
AN:
51334
Middle Eastern (MID)
AF:
0.713
AC:
4008
AN:
5620
European-Non Finnish (NFE)
AF:
0.733
AC:
765948
AN:
1044960
Other (OTH)
AF:
0.755
AC:
43637
AN:
57820
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
13168
26336
39503
52671
65839
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
18464
36928
55392
73856
92320
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.729
AC:
110756
AN:
152000
Hom.:
40657
Cov.:
0
AF XY:
0.734
AC XY:
54562
AN XY:
74302
show subpopulations
African (AFR)
AF:
0.669
AC:
27701
AN:
41418
American (AMR)
AF:
0.733
AC:
11202
AN:
15272
Ashkenazi Jewish (ASJ)
AF:
0.733
AC:
2541
AN:
3468
East Asian (EAS)
AF:
0.984
AC:
5094
AN:
5178
South Asian (SAS)
AF:
0.844
AC:
4072
AN:
4824
European-Finnish (FIN)
AF:
0.775
AC:
8178
AN:
10548
Middle Eastern (MID)
AF:
0.694
AC:
204
AN:
294
European-Non Finnish (NFE)
AF:
0.731
AC:
49715
AN:
67978
Other (OTH)
AF:
0.750
AC:
1584
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1510
3020
4529
6039
7549
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
850
1700
2550
3400
4250
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.686
Hom.:
4193
Bravo
AF:
0.717
Asia WGS
AF:
0.910
AC:
3165
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
Apr 09, 2025
Molecular Diagnostic Laboratory for Inherited Cardiovascular Disease, Montreal Heart Institute
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Wolff-Parkinson-White pattern Benign:1
Oct 25, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

not provided Benign:1
Jun 23, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Hypertrophic cardiomyopathy 6 Benign:1
Oct 25, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Lethal congenital glycogen storage disease of heart Benign:1
Oct 25, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
PhyloP100
-3.4
Mutation Taster
=28/72
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs35348247; hg19: chr7-151292395; API